# ePrime: Evaluation of Magnetic Resonance (MR) Imaging to Predict Neurodevelopmental Impairment in Preterm Infants

> **NCT01049594** · — · UNKNOWN · sponsor: **Imperial College London** · enrollment: 625 (estimated)

## Conditions studied

- Cerebral Palsy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01049594
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-04
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 625 (ESTIMATED)
- **Last updated:** 2015-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01049594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01049594, "ePrime: Evaluation of Magnetic Resonance (MR) Imaging to Predict Neurodevelopmental Impairment in Preterm Infants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01049594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*